De Mello, R.A.; Neves, N.M.; Amaral, G.A.; Lippo, E.G.; Castelo-Branco, P.; Pozza, D.H.; Tajima, C.C.; Antoniou, G.
The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer. J. Clin. Med. 2020, 9, 1918.
https://doi.org/10.3390/jcm9061918
AMA Style
De Mello RA, Neves NM, Amaral GA, Lippo EG, Castelo-Branco P, Pozza DH, Tajima CC, Antoniou G.
The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer. Journal of Clinical Medicine. 2020; 9(6):1918.
https://doi.org/10.3390/jcm9061918
Chicago/Turabian Style
De Mello, Ramon Andrade, Nathália Moisés Neves, Giovanna Araújo Amaral, Estela Gudin Lippo, Pedro Castelo-Branco, Daniel Humberto Pozza, Carla Chizuru Tajima, and Georgios Antoniou.
2020. "The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer" Journal of Clinical Medicine 9, no. 6: 1918.
https://doi.org/10.3390/jcm9061918
APA Style
De Mello, R. A., Neves, N. M., Amaral, G. A., Lippo, E. G., Castelo-Branco, P., Pozza, D. H., Tajima, C. C., & Antoniou, G.
(2020). The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer. Journal of Clinical Medicine, 9(6), 1918.
https://doi.org/10.3390/jcm9061918
